Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation

por Devins, Kyle, Schuster, Stephen J., Caponetti, Gabriel C., Bogusz, Agata M.
Publicado 2018

Efficacy and safety of CD19‐directed CAR‐T cell therapies in patients with relapsed/refractory aggressive B‐cell lymphomas: Observations from the JULIET, ZUMA‐1, and TRANSCEND tria...

por Westin, Jason R., Kersten, Marie José, Salles, Gilles, Abramson, Jeremy S., Schuster, Stephen J., Locke, Frederick L., Andreadis, Charalambos
Publicado 2021

Prediction of lymphoma response to CAR T cells by deep learning-based image analysis

por Tong, Yubing, Udupa, Jayaram K., Chong, Emeline, Winchell, Nicole, Sun, Changjian, Zou, Yongning, Schuster, Stephen J., Torigian, Drew A.
Publicado 2023

A Novel Approach for the Treatment of T Cell Malignancies: Targeting T Cell Receptor Vβ Families

por Wang, Jie, Urbanska, Katarzyna, Sharma, Prannda, Nejati, Reza, Shaw, Lauren, Lim, Megan S., Schuster, Stephen J., Jr., Daniel J. Powell
Publicado 2020

TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones

por Shaw, Lauren C., Poussin, Mathilde, Rodriguez-Garcia, Alba, Eggold, Joshua, Minutolo, Nicholas G., Wang, Jie, Rook, Alain H., Schuster, Stephen J., Powell, Daniel J.
Publicado 2022

Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS

por Nagle, Sarah J, Shah, Nirav N, Ganetsky, Alex, Landsburg, Daniel J, Nasta, Sunita D, Mato, Anthony, Schuster, Stephen J, Reshef, Ran, Tsai, Donald E, Svoboda, Jakub
Publicado 2017

The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma

por Nagle, Sarah J, Chong, Elise A, Chekol, Seble, Shah, Nirav N, Nasta, Sunita D, Glatstein, Eli, Plastaras, John P, Torigian, Drew A, Schuster, Stephen J, Svoboda, Jakub
Publicado 2015

Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial

por Fukuhara, Noriko, Kato, Koji, Goto, Hideki, Takeshi, Tajima, Kawaguchi, Mayu, Tokushige, Kota, Akashi, Koichi, Teshima, Takanori, Harigae, Hideo, Schuster, Stephen J., Thieblemont, Catherine, Dreyling, Martin, Fowler, Nathan
Publicado 2022

Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)

por Wang, Michael, Schuster, Stephen J., Phillips, Tycel, Lossos, Izidore S., Goy, Andre, Rule, Simon, Hamadani, Mehdi, Ghosh, Nilanjan, Reeder, Craig B., Barnett, Evelyn, Bravo, Marie-Laure Casadebaig, Martin, Peter
Publicado 2017

Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma

por Yamshon, Samuel, Chen, Gui Zhen, Gribbin, Caitlin, Christos, Paul, Shah, Bijal, Schuster, Stephen J., Smith, Sonali M., Svoboda, Jakub, Furman, Richard R., Leonard, John P., Martin, Peter, Ruan, Jia
Publicado 2023

Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial

por Balasubramanian, Sriram, Hodkinson, Brendan, Schuster, Stephen J., Fowler, Nathan H., Trotman, Judith, Hess, Georg, Cheson, Bruce D., Schaffer, Michael, Sun, Steven, Deshpande, Sanjay, Vermeulen, Jessica, Salles, Gilles, Gopal, Ajay K.
Publicado 2021

Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia

por Linaburg, Taylor, Davis, Adam R., Frey, Noelle V., Khawaja, Muhammad R., Landsburg, Daniel J., Schuster, Stephen J., Svoboda, Jakub, Li, Yimei, Borovskiy, Yuliya, Olson, Timothy S., Bagg, Adam, Hexner, Elizabeth O., Babushok, Daria V.
Publicado 2019

Genome-wide analysis of signatures of selection in populations of African honey bees (Apis mellifera) using new web-based tools

por Fuller, Zachary L., Niño, Elina L., Patch, Harland M., Bedoya-Reina, Oscar C., Baumgarten, Tracey, Muli, Elliud, Mumoki, Fiona, Ratan, Aakrosh, McGraw, John, Frazier, Maryann, Masiga, Daniel, Schuster, Stephen, Grozinger, Christina M., Miller, Webb
Publicado 2015

Safety and Efficacy of Sars-Cov-2 Vaccines in Hodgkin Lymphoma Patients Receiving PD-1 Inhibitors

por Svoboda, Jakub, Ballard, Hatcher J, Ho, Carrie I, Hughes, Mitchell E., Chong, Elise A, Duca, Adam, Prischak, Sara, Dwivedy Nasta, Sunita, Ruella, Marco, Landsburg, Daniel J, Barta, Stefan K., Gerson, James N, Schuster, Stephen J.
Publicado 2021

Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma Cells

por Zhang, Qian, Wang, Hong Y., Liu, Xiaobin, Roth, Michael H., Shestov, Alex A., Lee, Seung-Cheol, Jain, Kanika, Soderquist, Craig, Xiong, Qun-Bin, Ruella, Marco, Strauser, Honore, Glickson, Jerry D., Schuster, Stephen J., Ptasznik, Andrzej, Wasik, Mariusz A.
Publicado 2019

A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)

por Salles, Gilles, Schuster, Stephen J., Fischer, Luca, Kuruvilla, John, Patten, Piers E. M., von Tresckow, Bastian, Smith, Sonali, Jiménez-Ubieto, Ana, Davis, Keith L., Nagar, Saurabh, Zhang, Jie, Bollu, Vamsi, Jousseaume, Etienne, Ramos, Roberto, Wang, Yucai, Link, Brian K.
Publicado 2022

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

por Wudhikarn, Kitsada, Tomas, Ana Alarcon, Flynn, Jessica R., Devlin, Sean M., Brower, Jamie, Bachanova, Veronika, Nastoupil, Loretta J., McGuirk, Joseph P., Maziarz, Richard T., Oluwole, Olalekan O., Schuster, Stephen J., Porter, David L., Bishop, Michael R., Riedell, Peter A., Perales, Miguel-Angel
Publicado 2022

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

por Bhaskar, Shakthi T., Patel, Vivek G., Porter, David L., Schuster, Stephen J., Nastoupil, Loretta J., Perales, Miguel-Angel, Tomas, Ana Alarcon, Bishop, Michael R., McGuirk, Joseph P., Maziarz, Richard T., Chen, Andy I., Bachanova, Veronika, Maakaron, Joseph E., Riedell, Peter A., Oluwole, Olalekan O.
Publicado 2022

Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single‐agent ibrutinib

por Jones, Jeffrey A., Hillmen, Peter, Coutre, Steven, Tam, Constantine, Furman, Richard R., Barr, Paul M., Schuster, Stephen J., Kipps, Thomas J., Flinn, Ian W., Jaeger, Ulrich, Burger, Jan A., Cheng, Mei, Ninomoto, Joi, James, Danelle F., Byrd, John C., O'Brien, Susan M.
Publicado 2017

Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy

por Yegya-Raman, Nikhil, Wright, Christopher M., LaRiviere, Michael J., Baron, Jonathan A., Lee, Daniel Y., Landsburg, Daniel J., Svoboda, Jakub, Nasta, Sunita D., Gerson, James N., Barta, Stefan K., Chong, Elise A., Schuster, Stephen J., Maity, Amit, Facciabene, Andrea, Paydar, Ima, Plastaras, John P.
Publicado 2023